Effects of Alzheimer and Lewy Body Disease Pathologies on Brain Metabolism

Implication of metabolic and dopamine transporter PET in dementia with Lewy bodies

(2021) Sung Woo Kang et al.   Scientific Reports

Selective Disruption of Inhibitory Synapses Leading to Neuronal Hyperexcitability at an Early Stage of Tau Pathogenesis in a Mouse Model

(2020) Masafumi Shimojo et al.   JOURNAL OF NEUROSCIENCE

Cognitive tests aid in clinical differentiation of Alzheimer's disease versus Alzheimer's disease with Lewy body disease: Evidence from a pathological study

(2020) Martina Azar et al.   Alzheimers & Dementia

Subtypes of dementia with Lewy bodies are associated with α-synuclein and tau distribution

(2020) Tanis J. Ferman et al.   NEUROLOGY

Ablating Tau Reduces Hyperexcitability and Moderates Electroencephalographic Slowing in Transgenic Mice Expressing A53T Human α-Synuclein

(2020) Samuel T. Peters et al.   Frontiers in Neurology

Effects of Lewy body disease and Alzheimer disease on brain atrophy and cognitive dysfunction

(2019) Sung Woo Kang et al.   NEUROLOGY

Tau is required for progressive synaptic and memory deficits in a transgenic mouse model of α-synucleinopathy

(2019) Balvindar Singh et al.   ACTA NEUROPATHOLOGICA

Automated anatomical labelling atlas 3

(2019) Edmund T. Rolls et al.   NEUROIMAGE

Effects of Alzheimer's disease and Lewy body disease on subcortical atrophy

(2019) H. S. Yoo et al.   EUROPEAN JOURNAL OF NEUROLOGY

Distinguishing between dementia with Lewy bodies and Alzheimer's disease using metabolic patterns

(2019) Byoung Seok Ye et al.   NEUROBIOLOGY OF AGING

Metabolic correlates of dopaminergic loss in dementia with lewy bodies

(2019) Maria Huber et al.   MOVEMENT DISORDERS

CSF biomarkers of Alzheimer's disease concord with amyloid-β PET and predict clinical progression: A study of fully automated immunoassays in BioFINDER and ADNI cohorts

(2018) Oskar Hansson et al.   Alzheimers & Dementia

A53T mutant alpha-synuclein induces tau dependent postsynaptic impairment independent of neurodegenerative changes

(2018) Peter J. Teravskis et al.   JOURNAL OF NEUROSCIENCE

Amyloid-β-related and unrelated cortical thinning in dementia with Lewy bodies

(2018) Young-gun Lee et al.   NEUROBIOLOGY OF AGING

Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: a retrospective analysis

(2017) David J Irwin et al.   LANCET NEUROLOGY

Diagnosis and management of dementia with Lewy bodies

(2017) Ian G. McKeith et al.   NEUROLOGY

Distinct brain networks underlie cognitive dysfunction in Parkinson and Alzheimer diseases

(2016) Paul J. Mattis et al.   NEUROLOGY

Neuropathologically mixed Alzheimer’s and Lewy body disease: burden of pathological protein aggregates differs between clinical phenotypes

(2015) Lauren Walker et al.   ACTA NEUROPATHOLOGICA

Clinical Features of Alzheimer Disease With and Without Lewy Bodies

(2015) Eun Joo Chung et al.   JAMA Neurology

Clinicians' ability to diagnose dementia with Lewy bodies is not affected by  -amyloid load

(2015) P. Tiraboschi et al.   NEUROLOGY

Primary age-related tauopathy (PART): a common pathology associated with human aging

(2014) John F. Crary et al.   ACTA NEUROPATHOLOGICA

PART and SNAP

(2014) Clifford R. Jack   ACTA NEUROPATHOLOGICA

Alpha-synuclein and tau: teammates in neurodegeneration?

(2014) Simon Moussaud et al.   Molecular Neurodegeneration

Abnormal metabolic network activity in REM sleep behavior disorder

(2014) F. Holtbernd et al.   NEUROLOGY

Dementia with Lewy bodies: Basis of cingulate island sign

(2014) J. Graff-Radford et al.   NEUROLOGY

National Institute on Aging–Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach

(2011) Thomas J. Montine et al.   ACTA NEUROPATHOLOGICA

Atrophy-specific MRI brain template for Alzheimer's disease and mild cognitive impairment

(2011) Vladimir Fonov et al.   Alzheimers & Dementia

A Bayesian model of shape and appearance for subcortical brain segmentation

(2011) Brian Patenaude et al.   NEUROIMAGE

Autopsy consent, brain collection, and standardized neuropathologic assessment of ADNI participants: The essential role of the Neuropathology Core

(2010) Nigel J. Cairns et al.   Alzheimers & Dementia

Synergistic Interactions between A , Tau, and  -Synuclein: Acceleration of Neuropathology and Cognitive Decline

(2010) L. K. Clinton et al.   JOURNAL OF NEUROSCIENCE

Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction

(2009) Thomas G. Beach et al.   ACTA NEUROPATHOLOGICA

Alzheimer's Disease Neuroimaging Initiative (ADNI): Clinical characterization

(2009) R. C. Petersen et al.   NEUROLOGY

Argyrophilic grain disease

(2008) I. Ferrer et al.   BRAIN

Multicenter Standardized 18F-FDG PET Diagnosis of Mild Cognitive Impairment, Alzheimer's Disease, and Other Dementias

(2008) L. Mosconi et al.   JOURNAL OF NUCLEAR MEDICINE

Bayesian analysis of neuroimaging data in FSL

(2008) Mark W. Woolrich et al.   NEUROIMAGE